1. Svensson, J.R., Nygaard, L., Andersen, T.M., Weibel, H., Hjorth, T.B.: Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation. US Patent 5,866,590, 1999
2. Holtkamp, M., Pfeiffer, M., Buchheim, K., Meierkord, H.: Tiagabine and non-convulsive status epilepticus. Nervenarzt 70(12), 1104–1106 (1999)
3. Filip, M., Frankowska, M., Golda, A., Zaniewska, M., Vetulani, J., Przegalinski, E.: Various GABA-mimetic drugs differently affect cocaine-evoked hyperlocomotion and sensitization. Eur. J. Pharm. 541(3), 163–170 (2006)
4. Gonzalez, G., Desai, R., Sofuoglu, M., Poling, J., Oliveto, A., Gonsai, K., Kosten, T.R.: Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend. 87(1), 1–9 (2007)
5. Bauer, J., Bergmann, A., Reuber, M., Stodieck, S.R., Genton, P.: Tolerability of tiagabine: a prospective open-label study. Epileptic Disord. 4(4), 257–260 (2002)